CTNM Dividend History - Contineum Therapeutics Common

Currently (March 2025) Contineum Therapeutics, Inc. Class A Common Stock does not pay a dividend.

As of March 2025, Contineum Therapeutics Common (CTNM) does not pay a dividend.

Top Dividend Payers in Pharmaceuticals

Top Dividend Yield in Peer Group
Symbol Market Cap in USD Yield Yield on Cost
CTNM 166m 0.0% -
SIGA 504m 8.96% 18.6%
PFE 148,711m 6.48% 7.37%
OGN 3,983m 6.93% 4.09%
Top Dividend Grower in Peer Group
Symbol Market Cap in USD Grow Rating
CTNM 166m - 0.0%
FAGR 1,467m 30.3% 57.0%
COPN 1,193m 25.8% 49.3%
RPRX 19,029m 22.9% 68.8%

CTNM Dividend History

No dividends paid yet.

CTNM Dividend History - FAQ

Does CTNM pay dividends?

No, as of March 2025 CTNM does not pay a dividend.

What is the Dividend Yield of CTNM?

As of March 2025, CTNM`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 7.14.

How often does CTNM pay dividends?

Over the last 12 months (TTM), CTNM has issued 0 dividend payments.

What is the next Ex-Dividend Date for CTNM?

The next ex-dividend date for Contineum Therapeutics Common (CTNM) is unknown.

What is the Dividend Growth Rate of CTNM?

CTNM's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of CTNM?

CTNM's 5-Year Yield on Cost is -%. This represents the effective dividend yield for an investor who bought Contineum Therapeutics Common five years ago. It is calculated as the trailing 12-month dividend cash amount (-) divided by the purchase price five years ago (16.00):

What is the Payout Consistency of CTNM?

CTNM Payout Consistency is 0.0%.

Does CTNM have a good Dividend Yield?

CTNM`s 0.00% Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of CTNM?

The Dividend Payout Ratio of CTNM is unknown.

What is the Dividend Rating of CTNM?

CTNM`s Overall Dividend Rating is (unknown). Ratings surpassing 60 are regarded as favorable, exceeding 75 are strong, and surpassing 85 are exceptional.

Bonus Section: CTNM Outstanding Shares

What is the Trend of CTNM`s Outstanding Shares?

The Outstanding Shares of Contineum Therapeutics Common are growing at a rate of 0.79% per year on average over the last 5 years. The Correlation Coefficent of the Outstanding Shares is 86.6%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.

Did Contineum Therapeutics Common ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Growth Rate
2022 25,130,800
2023 25,130,800
2024 25,730,000 +2.38%